VXX-401

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameVXX-401
Drug Alias Namea vaccine designed to stimulate the production of endogenous antibodies against PCSK9（ Vaxxinity）VXX-401
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVaxxinity Inc
China Registration ClassN/A

Develop Information

Active CompaniesVaxxinity Inc
Inactive CompaniesN/A
Active IndicationsHypercholesterolemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A